121 related articles for article (PubMed ID: 3116959)
1. Medical therapy for chronic reflux esophagitis. Long-term follow-up.
Lieberman DA
Arch Intern Med; 1987 Oct; 147(10):1717-20. PubMed ID: 3116959
[TBL] [Abstract][Full Text] [Related]
2. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe reflux esophagitis with cimetidine and metoclopramide.
Lieberman DA; Keeffe EB
Ann Intern Med; 1986 Jan; 104(1):21-6. PubMed ID: 3940501
[TBL] [Abstract][Full Text] [Related]
4. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis.
Pace F; Sangaletti O; Bianchi Porro G
Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
6. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
[TBL] [Abstract][Full Text] [Related]
7. Current concepts in the pathogenesis and treatment of reflux esophagitis.
Frazier JL; Fendler KJ
Clin Pharm; 1983; 2(6):546-57. PubMed ID: 6360495
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
9. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
10. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
Pace F; Sangaletti O; Zhu H; Bianchi Porro G
Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
[TBL] [Abstract][Full Text] [Related]
11. Long-term therapy for chronic gastroesophageal reflux.
Castell DO
Arch Intern Med; 1987 Oct; 147(10):1701-2. PubMed ID: 3116958
[No Abstract] [Full Text] [Related]
12. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
13. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
Cappelli J; Morobe J; Van Laethem A; Musin L
Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
[TBL] [Abstract][Full Text] [Related]
14. Short and long-term outcome of medically treated reflux esophagitis.
Pace F; Sangaletti O; Trapé E; Santalucia F; Bianchi Porro GB
Hepatogastroenterology; 1995 Apr; 42(2):131-4. PubMed ID: 7672761
[TBL] [Abstract][Full Text] [Related]
15. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Sontag SJ; O'Connell S; Khandelwal S; Greenlee H; Schnell T; Nemchausky B; Chejfec G; Miller T; Seidel J; Sonnenberg A
Am J Gastroenterol; 2003 May; 98(5):987-99. PubMed ID: 12809818
[TBL] [Abstract][Full Text] [Related]
16. Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus.
Delpre G; Kadish U; Glanz I; Avidor I
Am J Gastroenterol; 1984 Jan; 79(1):8-11. PubMed ID: 6419585
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
Guslandi M; Testoni PA; Passaretti S; Masci E; Ballarin E; Comin U; Marchi R; Ronchi G; Tittobello A
Hepatogastroenterology; 1983 Jun; 30(3):96-8. PubMed ID: 6309637
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state.
Behar J; Biancani P
Gastroenterology; 1976 Mar; 70(3):331-5. PubMed ID: 765184
[TBL] [Abstract][Full Text] [Related]
19. Audit of reflux oesophagitis at 4 years.
Pace F; Bollani S; Manzionna G; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):355-60. PubMed ID: 9789126
[TBL] [Abstract][Full Text] [Related]
20. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
Singh P; Taylor RH; Colin-Jones DG
Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
